Safety and efficacy of IV theophylline for regadenoson-associated side effect reversal View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2022-07-07

AUTHORS

Courtney Shakowski, Vy A. Pham, Joshua Raines, Robert A. Quaife, Robert L. Page

ABSTRACT

BackgroundAminophylline injection has been on an intermittent nation-wide shortage due to manufacturing delays leaving a need for an alternative reversal agent for regadenoson-associated side effects. Intravenous theophylline should be a logical acceptable pharmacological alternative; however, data regarding its safety and efficacy as a reversal agent are lacking.MethodsUtilizing electronic medical records at the University of Colorado hospital, we identified patients ≥ 18 years of age who had a pharmacologic stress test using regadenoson during periods of aminophylline shortage (3/1/2013 to 5/31/2013 and 4/1/2018 to 8/30/2018) in which theophylline was used as an alternative antidote for side effect reversal. Intravenous theophylline was prepared by the inpatient pharmacy to a concentration of 0.8 mg/mL in a total volume of 100 mL D5W. Specific side effects and side effect resolution were evaluated.ResultsOf the 122 patients evaluated, theophylline was administered in doses ranging from 40 to 75 mg with the majority receiving 40 mg. Complete resolution of regadenoson side effects occurred in 98 patients with 12 experiencing partial resolution and 1 without resolution. No adverse effects or events were reported.ConclusionDue to limited availability of aminophylline, theophylline may be a safe and effective alternative to reverse regadenoson-associated side effects. More... »

PAGES

1-5

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12350-022-03031-3

DOI

http://dx.doi.org/10.1007/s12350-022-03031-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1149307346

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/35799037


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, University of Colorado Health, University of Colorado Hospital, Aurora, CO, USA", 
          "id": "http://www.grid.ac/institutes/grid.413085.b", 
          "name": [
            "Department of Pharmacy, University of Colorado Health, University of Colorado Hospital, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shakowski", 
        "givenName": "Courtney", 
        "id": "sg:person.010763612150.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010763612150.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Internal Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA", 
          "id": "http://www.grid.ac/institutes/grid.430503.1", 
          "name": [
            "Division of Internal Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pham", 
        "givenName": "Vy A.", 
        "id": "sg:person.013052224420.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013052224420.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hospital Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA", 
          "id": "http://www.grid.ac/institutes/grid.430503.1", 
          "name": [
            "Division of Hospital Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Raines", 
        "givenName": "Joshua", 
        "id": "sg:person.011015340026.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011015340026.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Nuclear Medicine, Department of Radiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA", 
          "id": "http://www.grid.ac/institutes/grid.430503.1", 
          "name": [
            "Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA", 
            "Division of Nuclear Medicine, Department of Radiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Quaife", 
        "givenName": "Robert A.", 
        "id": "sg:person.01203174600.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203174600.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA", 
          "id": "http://www.grid.ac/institutes/grid.430503.1", 
          "name": [
            "Department of Pharmacy, University of Colorado Health, University of Colorado Hospital, Aurora, CO, USA", 
            "Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Page", 
        "givenName": "Robert L.", 
        "id": "sg:person.01307317174.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307317174.83"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s12350-015-0387-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053436751", 
          "https://doi.org/10.1007/s12350-015-0387-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.nuclcard.2007.06.114", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035693866", 
          "https://doi.org/10.1016/j.nuclcard.2007.06.114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12350-011-9474-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026731210", 
          "https://doi.org/10.1007/s12350-011-9474-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12350-016-0452-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051461653", 
          "https://doi.org/10.1007/s12350-016-0452-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/j.nuclcard.2007.02.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007288648", 
          "https://doi.org/10.1016/j.nuclcard.2007.02.016"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2022-07-07", 
    "datePublishedReg": "2022-07-07", 
    "description": "BackgroundAminophylline injection has been on an intermittent nation-wide shortage due to manufacturing delays leaving a need for an alternative reversal agent for regadenoson-associated side effects. Intravenous theophylline should be a logical acceptable pharmacological alternative; however, data regarding its safety and efficacy as a reversal agent are lacking.MethodsUtilizing electronic medical records at the University of Colorado hospital, we identified patients \u2265 18 years of age who had a pharmacologic stress test using regadenoson during periods of aminophylline shortage (3/1/2013 to 5/31/2013 and 4/1/2018 to 8/30/2018) in which theophylline was used as an alternative antidote for side effect reversal. Intravenous theophylline was prepared by the inpatient pharmacy to a concentration of 0.8 mg/mL in a total volume of 100 mL D5W. Specific side effects and side effect resolution were evaluated.ResultsOf the 122 patients evaluated, theophylline was administered in doses ranging from 40 to 75 mg with the majority receiving 40 mg. Complete resolution of regadenoson side effects occurred in 98 patients with 12 experiencing partial resolution and 1 without resolution. No adverse effects or events were reported.ConclusionDue to limited availability of aminophylline, theophylline may be a safe and effective alternative to reverse regadenoson-associated side effects.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12350-022-03031-3", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1106202", 
        "issn": [
          "1071-3581", 
          "1532-6551"
        ], 
        "name": "Journal of Nuclear Cardiology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "side effects", 
      "intravenous theophylline", 
      "reversal agents", 
      "pharmacologic stress test", 
      "specific side effects", 
      "years of age", 
      "electronic medical records", 
      "pharmacological alternatives", 
      "Colorado Hospital", 
      "medical records", 
      "complete resolution", 
      "inpatient pharmacy", 
      "patients", 
      "adverse effects", 
      "theophylline", 
      "alternative antidote", 
      "effect reversal", 
      "partial resolution", 
      "effect resolution", 
      "stress test", 
      "effective alternative", 
      "efficacy", 
      "safety", 
      "regadenoson", 
      "ResultsOf", 
      "aminophylline", 
      "hospital", 
      "agents", 
      "doses", 
      "ConclusionDue", 
      "limited availability", 
      "age", 
      "effect", 
      "injection", 
      "D5W.", 
      "pharmacy", 
      "total volume", 
      "reversal", 
      "antidote", 
      "majority", 
      "years", 
      "period", 
      "records", 
      "alternative", 
      "events", 
      "test", 
      "shortage", 
      "volume", 
      "concentration", 
      "need", 
      "data", 
      "delay", 
      "resolution", 
      "availability", 
      "University", 
      "nations"
    ], 
    "name": "Safety and efficacy of IV theophylline for regadenoson-associated side effect reversal", 
    "pagination": "1-5", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1149307346"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12350-022-03031-3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "35799037"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12350-022-03031-3", 
      "https://app.dimensions.ai/details/publication/pub.1149307346"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:50", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_943.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12350-022-03031-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12350-022-03031-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12350-022-03031-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12350-022-03031-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12350-022-03031-3'


 

This table displays all metadata directly associated to this object as RDF triples.

170 TRIPLES      21 PREDICATES      84 URIs      71 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12350-022-03031-3 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N9749f3478a8c4ebb99b927c1b5c921d1
4 schema:citation sg:pub.10.1007/s12350-011-9474-9
5 sg:pub.10.1007/s12350-015-0387-x
6 sg:pub.10.1007/s12350-016-0452-0
7 sg:pub.10.1016/j.nuclcard.2007.02.016
8 sg:pub.10.1016/j.nuclcard.2007.06.114
9 schema:datePublished 2022-07-07
10 schema:datePublishedReg 2022-07-07
11 schema:description BackgroundAminophylline injection has been on an intermittent nation-wide shortage due to manufacturing delays leaving a need for an alternative reversal agent for regadenoson-associated side effects. Intravenous theophylline should be a logical acceptable pharmacological alternative; however, data regarding its safety and efficacy as a reversal agent are lacking.MethodsUtilizing electronic medical records at the University of Colorado hospital, we identified patients ≥ 18 years of age who had a pharmacologic stress test using regadenoson during periods of aminophylline shortage (3/1/2013 to 5/31/2013 and 4/1/2018 to 8/30/2018) in which theophylline was used as an alternative antidote for side effect reversal. Intravenous theophylline was prepared by the inpatient pharmacy to a concentration of 0.8 mg/mL in a total volume of 100 mL D5W. Specific side effects and side effect resolution were evaluated.ResultsOf the 122 patients evaluated, theophylline was administered in doses ranging from 40 to 75 mg with the majority receiving 40 mg. Complete resolution of regadenoson side effects occurred in 98 patients with 12 experiencing partial resolution and 1 without resolution. No adverse effects or events were reported.ConclusionDue to limited availability of aminophylline, theophylline may be a safe and effective alternative to reverse regadenoson-associated side effects.
12 schema:genre article
13 schema:isAccessibleForFree false
14 schema:isPartOf sg:journal.1106202
15 schema:keywords Colorado Hospital
16 ConclusionDue
17 D5W.
18 ResultsOf
19 University
20 adverse effects
21 age
22 agents
23 alternative
24 alternative antidote
25 aminophylline
26 antidote
27 availability
28 complete resolution
29 concentration
30 data
31 delay
32 doses
33 effect
34 effect resolution
35 effect reversal
36 effective alternative
37 efficacy
38 electronic medical records
39 events
40 hospital
41 injection
42 inpatient pharmacy
43 intravenous theophylline
44 limited availability
45 majority
46 medical records
47 nations
48 need
49 partial resolution
50 patients
51 period
52 pharmacologic stress test
53 pharmacological alternatives
54 pharmacy
55 records
56 regadenoson
57 resolution
58 reversal
59 reversal agents
60 safety
61 shortage
62 side effects
63 specific side effects
64 stress test
65 test
66 theophylline
67 total volume
68 volume
69 years
70 years of age
71 schema:name Safety and efficacy of IV theophylline for regadenoson-associated side effect reversal
72 schema:pagination 1-5
73 schema:productId N2491564136f84d19b6e869dd39b2450b
74 N35b83043001c4ea9bf6272491e14a1fc
75 N97f52737b5d343a9a9126f4770563184
76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1149307346
77 https://doi.org/10.1007/s12350-022-03031-3
78 schema:sdDatePublished 2022-10-01T06:50
79 schema:sdLicense https://scigraph.springernature.com/explorer/license/
80 schema:sdPublisher Nad782546701649eea98e4d31747ec8b5
81 schema:url https://doi.org/10.1007/s12350-022-03031-3
82 sgo:license sg:explorer/license/
83 sgo:sdDataset articles
84 rdf:type schema:ScholarlyArticle
85 N2491564136f84d19b6e869dd39b2450b schema:name doi
86 schema:value 10.1007/s12350-022-03031-3
87 rdf:type schema:PropertyValue
88 N35b83043001c4ea9bf6272491e14a1fc schema:name pubmed_id
89 schema:value 35799037
90 rdf:type schema:PropertyValue
91 N411f4f5141e0495eaef3d52f7e0cd9be rdf:first sg:person.01203174600.81
92 rdf:rest N678bd6c71bb84feca7e29d2ebdff7802
93 N678bd6c71bb84feca7e29d2ebdff7802 rdf:first sg:person.01307317174.83
94 rdf:rest rdf:nil
95 N8b657cc4bffa49da8d9cff888df42586 rdf:first sg:person.013052224420.87
96 rdf:rest Nfeb99417860242f3802ea6fc1d5798c5
97 N9749f3478a8c4ebb99b927c1b5c921d1 rdf:first sg:person.010763612150.63
98 rdf:rest N8b657cc4bffa49da8d9cff888df42586
99 N97f52737b5d343a9a9126f4770563184 schema:name dimensions_id
100 schema:value pub.1149307346
101 rdf:type schema:PropertyValue
102 Nad782546701649eea98e4d31747ec8b5 schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 Nfeb99417860242f3802ea6fc1d5798c5 rdf:first sg:person.011015340026.23
105 rdf:rest N411f4f5141e0495eaef3d52f7e0cd9be
106 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
107 schema:name Medical and Health Sciences
108 rdf:type schema:DefinedTerm
109 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
110 schema:name Clinical Sciences
111 rdf:type schema:DefinedTerm
112 sg:journal.1106202 schema:issn 1071-3581
113 1532-6551
114 schema:name Journal of Nuclear Cardiology
115 schema:publisher Springer Nature
116 rdf:type schema:Periodical
117 sg:person.010763612150.63 schema:affiliation grid-institutes:grid.413085.b
118 schema:familyName Shakowski
119 schema:givenName Courtney
120 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010763612150.63
121 rdf:type schema:Person
122 sg:person.011015340026.23 schema:affiliation grid-institutes:grid.430503.1
123 schema:familyName Raines
124 schema:givenName Joshua
125 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011015340026.23
126 rdf:type schema:Person
127 sg:person.01203174600.81 schema:affiliation grid-institutes:grid.430503.1
128 schema:familyName Quaife
129 schema:givenName Robert A.
130 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01203174600.81
131 rdf:type schema:Person
132 sg:person.013052224420.87 schema:affiliation grid-institutes:grid.430503.1
133 schema:familyName Pham
134 schema:givenName Vy A.
135 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013052224420.87
136 rdf:type schema:Person
137 sg:person.01307317174.83 schema:affiliation grid-institutes:grid.430503.1
138 schema:familyName Page
139 schema:givenName Robert L.
140 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307317174.83
141 rdf:type schema:Person
142 sg:pub.10.1007/s12350-011-9474-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026731210
143 https://doi.org/10.1007/s12350-011-9474-9
144 rdf:type schema:CreativeWork
145 sg:pub.10.1007/s12350-015-0387-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1053436751
146 https://doi.org/10.1007/s12350-015-0387-x
147 rdf:type schema:CreativeWork
148 sg:pub.10.1007/s12350-016-0452-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051461653
149 https://doi.org/10.1007/s12350-016-0452-0
150 rdf:type schema:CreativeWork
151 sg:pub.10.1016/j.nuclcard.2007.02.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007288648
152 https://doi.org/10.1016/j.nuclcard.2007.02.016
153 rdf:type schema:CreativeWork
154 sg:pub.10.1016/j.nuclcard.2007.06.114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035693866
155 https://doi.org/10.1016/j.nuclcard.2007.06.114
156 rdf:type schema:CreativeWork
157 grid-institutes:grid.413085.b schema:alternateName Department of Pharmacy, University of Colorado Health, University of Colorado Hospital, Aurora, CO, USA
158 schema:name Department of Pharmacy, University of Colorado Health, University of Colorado Hospital, Aurora, CO, USA
159 rdf:type schema:Organization
160 grid-institutes:grid.430503.1 schema:alternateName Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
161 Division of Hospital Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA
162 Division of Internal Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA
163 Division of Nuclear Medicine, Department of Radiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA
164 schema:name Department of Clinical Pharmacy, University of Colorado Anschutz Medical Campus, Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA
165 Department of Pharmacy, University of Colorado Health, University of Colorado Hospital, Aurora, CO, USA
166 Division of Cardiology, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA
167 Division of Hospital Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA
168 Division of Internal Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA
169 Division of Nuclear Medicine, Department of Radiology, University of Colorado Anschutz Medical Campus, School of Medicine, Aurora, CO, USA
170 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...